Search Results - "Albrechtsen, D"

Refine Results
  1. 1
  2. 2

    Mycophenolate mofetil in renal transplantation : 3-year results from the placebo-controlled trial by Vanrenterghem, Y

    Published in Transplantation (15-08-1999)
    “…The European double-blind, placebo-(PLA) controlled study of mycophenolate mofetil (MMF) for prevention of acute renal allograft rejection showed that MMF 2…”
    Get full text
    Journal Article
  3. 3

    Impact of numeracy preferences on information needs for genome sequencing results by Albrechtsen, Richard D., Goodman, Melody S., Bather, Jemar R., Kaphingst, Kimberly A.

    Published in Patient education and counseling (01-03-2021)
    “…•Numeracy was assessed using the Subjective Numeracy Scale with subscales distinguishing ability and preferences.•Patient interest in information related to…”
    Get full text
    Journal Article
  4. 4

    A randomised study of allogeneic transplantation with stem cells from blood or bone marrow by HELDAL, D, TJØNNFJORD, G, BRINCH, L, ALBRECHTSEN, D, EGELAND, T, STEEN, R, SOLHEIM, B. G, EVENSEN, S. A

    Published in Bone marrow transplantation (Basingstoke) (01-06-2000)
    “…Sixty-one consecutive adult patients with leukaemia, primary myelofibrosis or myelodysplastic syndrome with an HLA-identical or one antigen mismatched family…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function by Odell, Daniel W, Albrechtsen, Richard D, Sindt, Jill E, Gole, Ryan, Brown, Spencer, Parsons, Matthew W, Paxton, Adam B, Sarkar, Vikren, Lloyd, Shane, Brogan, Shane E, Tao, Randa

    Published in Neuromodulation (Malden, Mass.) (01-10-2021)
    “…Radiation therapy (RT) and intrathecal drug delivery systems (IDDS) are often used concurrently to optimize pain management in patients with cancer. Concern…”
    Get more information
    Journal Article
  7. 7

    Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints by HELDAL, D, BRINCH, L, TJØNNFJORD, G, SOLHEIM, B. G, EGELAND, T, GADEHOLT, G, ALBRECHTSEN, D, AAMODT, G, EVENSEN, S. A

    Published in Bone marrow transplantation (Basingstoke) (01-03-2002)
    “…Biological consequences and physical complaints were compared for donors randomly assigned either to blood stem cell (BSC) or bone marrow (BM) donation. In the…”
    Get full text
    Journal Article
  8. 8

    Experience with cyclosporine in 1519 kidney transplantations from living donors in a national transplant programme, 1983–2002 by Albrechtsen, D, Leivestad, T, Brekke, I, Fauchald, P, Pfeffer, P, Thorsby, E

    Published in Transplantation proceedings (01-03-2004)
    “…Following the introduction of cyclosporine as basic immunosuppression in our national transplant programme in 1983, the pool of grafts from living donors (LDs)…”
    Get full text
    Journal Article
  9. 9

    No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients by RUUTU, T, LJUNGMAN, P, EBELING, F, MYLLYLÄ, G, BRINCH, L, LENHOFF, S, LÖNNQVIST, B, RINGDEN, O, RUUTU, P, VOLIN, L, ALBRECHTSEN, D, SALLERFORS, B

    Published in Bone marrow transplantation (Basingstoke) (01-02-1997)
    “…A randomized multicentre study was conducted to evaluate the effect of anti-CMV hyperimmune globulin in the prophylaxis of CMV infections in CMV seronegative…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients by Kovarik, J M, Rawlings, E, Sweny, P, Fernando, O, Moore, R, Griffin, P J, Fauchald, P, Albrechtsen, D, Sodal, G, Nordal, K, Amlot, P L

    Published in Transplant international (1996)
    “…SDZ CHI 621 is a murine-human chimeric monoclonal antibody (mAb) to the interleukin-2 (IL-2) receptor (CD25) intended for prophylactic immunosuppression…”
    Get more information
    Journal Article
  12. 12

    HLA-D-associated 'Ia-like' antigens on human macrophages by Albrechtsen, D

    Published in Scandinavian journal of immunology (01-01-1977)
    “…Human macrophages procured by culture of adherent peripheral blood mononuclear cells were investigated for reactivity in complement-dependent cytotoxicity…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    HLA-A incompatibility associated with enhanced long-term renal graft survival in HLA-B, DR mismatched transplants by Bućin, D, Ekberg, H, Lindholm, A, Persson, H, Tufveson, G, Albrechtsen, D

    Published in Immunology and cell biology (01-12-1994)
    “…The effect of HLA-A matching on long-term cadaver kidney graft survival was analysed, on average, 6 years after transplantation in a total of 1085 cyclosporine…”
    Get more information
    Journal Article
  17. 17
  18. 18

    The use of elderly living donors in renal transplantation by Fauchald, P, Sødal, G, Albrechtsen, D, Leivestad, T, Berg, K J, Flatmark, A

    Published in Transplant international (01-01-1991)
    “…The safety and the results of using living donors above the age of 60 years were studied. In 235 consecutive donors the complications were not different in…”
    Get more information
    Journal Article
  19. 19

    Intra-operative haemodynamic findings and their prognostic significance in femoropopliteal reversed saphenous vein graft bypass operations by Albrechtsen, D

    “…Post-reconstructive graft blood flow (basal flow') was measured by means of an electromagnetic flowmeter in 72 consecutive femoropopliteal reversed saphenous…”
    Get more information
    Journal Article
  20. 20

    The national kidney transplant program in Norway still results in unchanged waiting lists by Bentdal, O H, Leivestad, T, Fauchald, P, Albrechtsen, D, Pfeffer, P, Lien, B, Foss, A, Oyen, O, Hartmann, A, Nordal, K, Sødal, G, Flatmark, A, Thorsby, E, Brekke, I B

    Published in Clinical transplants (1998)
    “…1. Of 2,670 patients starting renal replacement therapy for end-stage renal disease in Norway from 1989-1997, 76% were candidates for transplantation. The…”
    Get more information
    Journal Article